Could a cheap epilepsy drug ease chronic nerve pain?
NCT ID NCT02100046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether ethosuximide, a drug already used for epilepsy, can reduce pain in people with nerve damage. 114 adults with peripheral neuropathic pain took either the drug or a placebo for 42 days. Researchers measured pain levels and quality of life to see if the drug offers a new, affordable option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ethosuximide (Zarontin)
- What this could lead to
- If it works, this could point toward a new, affordable treatment option for nerve pain that doesn't respond to current medications.
- What could go wrong
- This is an early Phase 2 trial with only 114 people, so results may not apply to everyone. Ethosuximide is an epilepsy drug and may cause side effects like drowsiness or stomach upset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN DIAGNOSTIC QUESTIONNAIRE (DN4) ≥ 4 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could common nerve pain drugs be quietly affecting the heart?
- Simple blood test may predict nerve block success for chronic pain sufferers
- VA launches major trial of THC and CBD for Veterans' nerve pain
- Laser light offers hope for chemo nerve pain in new trial
- New nerve pain drug shows promise in Year-Long trial
- Can sound waves soothe pain? new device tested on healthy volunteers